Provider review
Kongo review
Publishes a comparison table with figures in both columns.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$119/mo semaglutide and $229/mo tirzepatide
Visit KongoIts own column is checkable. The competitor column names nobody and sources nothing.
Price as published
Kongo
$119/mo semaglutide and $229/mo tirzepatide
- Vs median
- $56/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
A comparison table with figures on both sides is an unusual thing to publish and it is worth reading in two halves. The half you can act on is its own pricing: five products, each with a plain monthly rate, visible without an intake, with a three-month view available beside the monthly one. That is more than most providers manage and it makes the site genuinely comparable against others. The other half is not evidence of anything. The competitor column names nobody, sources nothing, and attributes figures to an unnamed group described only as the other guys — so what it establishes is what this seller would like you to believe about the market, not anything about the market itself. Read the left column and ignore the right, and the page is a useful one. No milligram appears against any product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want plain monthly rates for several products without an intake
- You want to compare a monthly and a three-month view side by side
- You are buying more than one product and want consistent pricing
Look elsewhere if
- You are relying on the comparison column — it is unsourced
- You want to know what a working dose costs
- You want a dose behind the number
What it actually costs
Price as published
$119/mo semaglutide and $229/mo tirzepatide
- Vs median
- $56/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. No low-dose product, but plain monthly rates for five products published without an intake, with a three-month view alongside. The competitor column beside them is unsourced and names nobody, so it establishes what the seller wants a reader to believe about the market rather than anything about it. The half that is checkable is worth reading; the half that is not should be ignored.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Publishes plain monthly rates for five products without an intake.
- Offers a monthly and a three-month view of the same table.
- Its own figures are specific and consistent across products.
Pharmacy, labs and oversight
Kongo does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Kongo publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
A comparison table with figures in both columns is an unusual thing to publish and it is worth reading in two halves. The half that is checkable is its own pricing: five products, each with a plain monthly rate, visible without an intake, with a three-month view available beside the monthly one. That is more than most of this page manages and it is the part a reader can act on. The other half is not evidence. The competitor column names nobody, sources nothing, and attributes figures to an unnamed group described as the other guys — so it establishes what this seller wants a reader to believe about the market rather than anything about the market. Read the left column and ignore the right. No milligram appears against any product.
The honest cons
The competitor column is unsourced and names nobody.
- The comparison invites a conclusion the page provides no way to check.
- No milligram appears against any product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Kongo is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Kongo does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#365 of 548
Ordered with the companies that pay us first, and Kongo is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Direct Meds
From $249/mo sublingual · $297/mo injection
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by CraftedRx · ChemistryRx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Direct Meds review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.